Migraine and Two-Pore-Domain Potassium Channels
Migraine is a common, disabling neurological disorder with a genetic, environmental, and hormonal component with an annual prevalence estimated at ~15%. It is characterized by attacks of severe, usually unilateral and throbbing headache, and can be accompanied by nausea, vomiting, and photophobia. Migraine is clinically divided into two main subtypes: migraine with aura, when it is preceded by transient neurological disturbances due to cortical spreading depression (CSD), and migraine without aura. Activation and sensitization of trigeminal sensory neurons, leading to the release of pro-inflammatory peptides, is likely a key component in headache pain initiation and transmission in migraine. In the present review, we will focus on the function of two-pore-domain potassium (K2P) channels, which control trigeminal sensory neuron excitability and their potential interest for developing new drugs to treat migraine.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
---|---|
Enthalten in: |
The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry - 27(2021), 3 vom: 04. Juni, Seite 268-284 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Verkest, Clément [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 17.01.2022 Date Revised 17.01.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1177/1073858420940949 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM312917724 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM312917724 | ||
003 | DE-627 | ||
005 | 20231225145441.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1177/1073858420940949 |2 doi | |
028 | 5 | 2 | |a pubmed24n1043.xml |
035 | |a (DE-627)NLM312917724 | ||
035 | |a (NLM)32715910 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Verkest, Clément |e verfasserin |4 aut | |
245 | 1 | 0 | |a Migraine and Two-Pore-Domain Potassium Channels |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.01.2022 | ||
500 | |a Date Revised 17.01.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Migraine is a common, disabling neurological disorder with a genetic, environmental, and hormonal component with an annual prevalence estimated at ~15%. It is characterized by attacks of severe, usually unilateral and throbbing headache, and can be accompanied by nausea, vomiting, and photophobia. Migraine is clinically divided into two main subtypes: migraine with aura, when it is preceded by transient neurological disturbances due to cortical spreading depression (CSD), and migraine without aura. Activation and sensitization of trigeminal sensory neurons, leading to the release of pro-inflammatory peptides, is likely a key component in headache pain initiation and transmission in migraine. In the present review, we will focus on the function of two-pore-domain potassium (K2P) channels, which control trigeminal sensory neuron excitability and their potential interest for developing new drugs to treat migraine | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Review | |
650 | 4 | |a K2P channels | |
650 | 4 | |a KCNK | |
650 | 4 | |a Kozac sequence | |
650 | 4 | |a allodynia | |
650 | 4 | |a excitability | |
650 | 4 | |a frameshift mutation-induced alternative translation initiation (fsATI) | |
650 | 4 | |a heterodimerization | |
650 | 4 | |a migraine | |
650 | 4 | |a trigeminal sensory neurons | |
650 | 7 | |a Potassium Channels |2 NLM | |
700 | 1 | |a Häfner, Stephanie |e verfasserin |4 aut | |
700 | 1 | |a Ávalos Prado, Pablo |e verfasserin |4 aut | |
700 | 1 | |a Baron, Anne |e verfasserin |4 aut | |
700 | 1 | |a Sandoz, Guillaume |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry |d 1996 |g 27(2021), 3 vom: 04. Juni, Seite 268-284 |w (DE-627)NLM094465770 |x 1089-4098 |7 nnns |
773 | 1 | 8 | |g volume:27 |g year:2021 |g number:3 |g day:04 |g month:06 |g pages:268-284 |
856 | 4 | 0 | |u http://dx.doi.org/10.1177/1073858420940949 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 27 |j 2021 |e 3 |b 04 |c 06 |h 268-284 |